New pill takes aim at hard-to-treat blood cancers
NCT ID NCT04609826
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a new drug called JNJ-74856665 in 153 people with acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), or chronic myelomonocytic leukemia (CMML). The main goals were to find safe doses and check for side effects when given alone or with other treatments. Participants had cancers that came back or did not respond to standard therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Asan Medical Center
Seoul, 05505, South Korea
-
CHRU Tours Hopital Bretonneau
Tours, 37000, France
-
CHU de Nice Hopital de l Archet
Nice, 06200, France
-
Centre Hospitalier Universitaire (CHU) de Bordeaux Hopital HautLeveque Centre Francois Magendie
Pessac, 33600, France
-
Clinica Univ. de Navarra
Pamplona, 31008, Spain
-
Hopital Saint Louis
Paris, 75010, France
-
Hosp Clinic de Barcelona
Barcelona, 08036, Spain
-
Hosp Univ Fund Jimenez Diaz
Madrid, 28040, Spain
-
Hosp Univ Vall D Hebron
Barcelona, 08035, Spain
-
Hosp. Univ. Marques de Valdecilla
Santander, 39008, Spain
-
Inst. Cat. Doncologia-H Duran I Reynals
Barcelona, 08908, Spain
-
Institut Universitaire du Cancer Toulouse Oncopole
Toulouse, 31059, France
-
Kings College Hospital
London, SE5 9RF, United Kingdom
-
Leicester Royal Infirmary
Leicester, LE1 5WW, United Kingdom
-
Samsung Medical Center
Seoul, 06351, South Korea
-
Seoul National University Hospital
Seoul, 3080, South Korea
-
Severance Hospital Yonsei University Health System
Seoul, 03722, South Korea
-
The Catholic University of Korea Seoul St Marys Hospital
Seoul, 06591, South Korea
-
The Christie Nhs Foundation Trust
Manchester, M20 4BX, United Kingdom
-
University College London Hospitals
London, NW1 2BU, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill keep blood cancer at bay after a stem cell transplant?
- Could muscle loss predict blood cancer outcomes?
- Can a modified enzyme starve Hard-to-Treat blood cancers?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?